Cargando…
Review of the Clinical Experiences of Feeding Infants Formula Containing the Human Milk Oligosaccharide 2′-Fucosyllactose
Human milk oligosaccharides (HMOs) are the third most abundant solid component in human milk after lactose and lipids. Preclinical research has demonstrated that HMOs and specifically 2′-fucosyllactose (2′-FL) are more than a prebiotic and have multiple functions, including immune, gut, and cognitio...
Autores principales: | Reverri, Elizabeth J., Devitt, Amy A., Kajzer, Janice A., Baggs, Geraldine E., Borschel, Marlene W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213476/ https://www.ncbi.nlm.nih.gov/pubmed/30241407 http://dx.doi.org/10.3390/nu10101346 |
Ejemplares similares
-
Growth, Tolerance, and Compliance of Infants Fed an Extensively Hydrolyzed Infant Formula with Added 2′-FL Fucosyllactose (2′-FL) Human Milk Oligosaccharide
por: Ramirez-Farias, Carlett, et al.
Publicado: (2021) -
Human Milk Oligosaccharides: 2′-Fucosyllactose (2′-FL) and Lacto-N-Neotetraose (LNnT) in Infant Formula
por: Vandenplas, Yvan, et al.
Publicado: (2018) -
Growth and Gastrointestinal Tolerance in Healthy Term Infants Fed Milk-Based Infant Formula Supplemented with Five Human Milk Oligosaccharides (HMOs): A Randomized Multicenter Trial
por: Lasekan, John, et al.
Publicado: (2022) -
Metabolism of the predominant human milk oligosaccharide fucosyllactose by an infant gut commensal
por: James, Kieran, et al.
Publicado: (2019) -
Comparison of Growth of Healthy Term Infants Fed Extensively Hydrolyzed Protein- and Amino Acid-Based Infant Formulas
por: Borschel, Marlene W., et al.
Publicado: (2018)